Home › Funds › Long Focus Capital Management, LLC › BNTX
Long Focus Capital Management, LLC position in BNTX
BIONTECH SE · Health Care
Long Focus Capital Management, LLC reported holding 624,000 shares of BNTX (BIONTECH SE) in its Q2 2026 13F filing — a position valued at US$58.1M, representing 2.30% of its reported portfolio and ranking #13 among its reported holdings. Long Focus Capital Management, LLC has disclosed BNTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Long Focus Capital Management, LLC's BNTX position evolved
Long Focus Capital Management, LLC first disclosed a stake in BNTX in Q4 2024 at 910,000 shares (US$103.7M). Across 7 filings, Long Focus Capital Management, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 624,000 shares valued at US$58.1M. Notable position changes include a 83% trim in Q1 2025 (shares rose 17% over the following quarter), a 31% increase in Q2 2025 (shares fell 7% over the following quarter), a 91% increase in Q3 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 910.00K | $103.69M | New |
| Q1 2025 | 159.00K | $14.48M | Reduce |
| Q2 2025 | 207.90K | $22.14M | Add |
| Q3 2025 | 397.65K | $39.22M | Add |
| Q4 2025 | 507.65K | $48.33M | Add |
| Q1 2026 | 624.00K | $55.46M | Add |
| Q2 2026 | 624.00K | $58.06M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 34 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- FLOSSBACH VON STORCH SE 2.23M sh · $207.14M · Q2 2026
- Temasek Holdings (Private) Ltd 1.51M sh · $140.14M · Q2 2026
- Logos Global Management LP 1.01M sh · $94.45M · Q2 2026
- GSK plc 889.82K sh · $82.80M · Q2 2026
- Davern Capital Partners, LP 754.55K sh · $70.21M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $43.73M · Q2 2026
More on Long Focus Capital Management, LLC
FAQ
How long has Long Focus Capital Management, LLC held BNTX?
Long Focus Capital Management, LLC has disclosed BNTX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Long Focus Capital Management, LLC's current position in BNTX?
As of Q2 2026, Long Focus Capital Management, LLC holds 624.00K shares of BNTX (BIONTECH SE), valued at $58.06M, representing 2.30% of its reported portfolio and ranking #13.
Has Long Focus Capital Management, LLC been buying or selling BNTX?
In the latest 13F filing (Q2 2026), Long Focus Capital Management, LLC held unchanged its position in BNTX.
Which other funds hold BNTX?
Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.